Literature DB >> 17192730

Use of fibrin sealant in hypospadias surgical repair reduces the frequency of postoperative complications.

Gabriela Ambriz-González1, Gabriela A Velázquez-Ramírez, José Luis García-González, José Manuel García de León-Gómez, María Ivette Muciño-Hernández, Alejandro González-Ojeda, Jaime Vargas Basterra.   

Abstract

INTRODUCTION: Urethrocutaneous fistulas (UCF) and flap dehiscence (FD) are the most common postoperative complications after hypospadias (HS) surgical repair. The aim of this study was to evaluate whether the application of fibrin sealant over the site of surgery and suture lines reduces these complications.
MATERIALS AND METHODS: A prospective cohort of consecutive patients was treated over a 3-year period. 30 patients were submitted to HS surgical repair plus application of fibrin glue over the suture line and surgical site; for comparison, another 56 subjects made up the control group which was submitted to surgical repair only. Variables assessed included: age, type of HS, fibrin sealant used, complications and number of surgical procedures required to treat recurrences.
RESULTS: In general, the frequency of complications was 10 vs. 41% for UCF (p = 0.002), 13 vs. 50% for FD (p = 0.001), and for flap necrosis (FN) 6.7 vs. 28.6% (p = 0.01) for the treatment and control groups respectively. The number of surgical reinterventions to treat recurrences was higher in the control group than in the study group (p = 0.04).
CONCLUSION: The incidence of UCF after HS surgical repair can be reduced by applying fibrin sealant over the site of surgery and the suture lines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17192730     DOI: 10.1159/000096932

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  8 in total

1.  The application of tissue-engineered preputial matrix and fibrin sealant for urethral reconstruction in rabbit model.

Authors:  Abdol-Mohammad Kajbafzadeh; Shabnam Sabetkish; Ali Tourchi; Naser Amirizadeh; Kourosh Afshar; Hassan Abolghasemi; Azadeh Elmi; Saman Shafaat Talab; Peyman Eshghi; Mohammad Javad Mohseni
Journal:  Int Urol Nephrol       Date:  2014-03-12       Impact factor: 2.370

2.  Looking beyond the dartos fascia and tunica vaginalis: reviewing the stance of common adjuvant covering biomaterials in hypospadiology.

Authors:  Sachit Anand; Hüseyin Özbey; Shilpa Sharma
Journal:  Am J Clin Exp Urol       Date:  2022-04-15

Review 3.  The use of tissue sealant in reducing urethrocutaneous fistula event following hypospadias repair: A systematic review and meta-analysis.

Authors:  Tomy Nurtamin; Johan Renaldo; Yudhistira Pradnyan Kloping; Ilham Akbar Rahman; Lukman Hakim
Journal:  Ann Med Surg (Lond)       Date:  2022-05-13

4.  Use of BioGlue Surgical Adhesive in Hypospadias Repair.

Authors:  Stanislav Kocherov; Genady Lev; Boris Chertin
Journal:  Curr Urol       Date:  2014-02-10

5.  Use of autologous platelet rich fibrin in urethracutaneous fistula repair: preliminary report.

Authors:  Tutku Soyer; Murat Çakmak; Mustafa K Aslan; Mine F Şenyücel; Üçler Kisa
Journal:  Int Wound J       Date:  2012-05-09       Impact factor: 3.315

6.  Evolution of hemostatic agents in surgical practice.

Authors:  Chandru P Sundaram; Alison C Keenan
Journal:  Indian J Urol       Date:  2010-07

7.  2-octyl cyanoacrylate versus reintervention for closure of urethrocutaneous fistulae after urethroplasty for hypospadias: a randomized controlled trial.

Authors:  Gabriela Ambriz-González; Pedro Aguirre-Ramirez; José Manuel García-de León; Francisco Javier León-Frutos; Sergio Adrián Montero-Cruz; Xóchitl Trujillo; Clotilde Fuentes-Orozco; Michel Dassaejv Macías-Amezcua; Andrea del Socorro Álvarez-Villaseñor; Ana Olivia Cortés-Flores; Mariana Chávez-Tostado; Alejandro González-Ojeda
Journal:  BMC Urol       Date:  2014-11-21       Impact factor: 2.264

8.  Acute postoperative complications of hypospadias repair.

Authors:  Amilal Bhat; Arup Kumar Mandal
Journal:  Indian J Urol       Date:  2008-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.